SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,623.57 |
| Enterprise Value ($M) | 1,524.52 |
| Book Value ($M) | 376.86 |
| Book Value / Share | 5.32 |
| Price / Book | 4.31 |
| NCAV ($M) | 319.30 |
| NCAV / Share | 4.51 |
| Price / NCAV | 5.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.44 |
| Return on Assets (ROA) | -0.57 |
| Return on Equity (ROE) | -0.76 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.28 |
| Current Ratio | 5.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 456.04 |
| Assets | 513.60 |
| Liabilities | 136.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Wasatch Advisors Inc | |||
| 13G/A | Baker Bros. Advisors Lp | 9.70 | 36.33 | |
| 13G/A | Redmile Group, LLC | 9.90 | 38.80 | |
| 13G/A | Sands Arthur T | 4.70 | 20.86 | |
| 13G | Wellington Management Group Llp | 5.41 | 199.58 | |
| 13G/A | Morgan Stanley | 2.70 | -43.27 | |
| 13G/A | BlackRock, Inc. | 10.20 | 30.11 | |
| 13G/A | Price T Rowe Associates Inc /md/ | 4.90 | -26.49 | |
| 13G/A | Deep Track Capital, LP | 6.18 | 10.33 | |
| 13G | Vanguard Group Inc | 5.36 | ||
| 13G | ARK Investment Management LLC | 6.59 | ||
| 13G/A | State Street Corp | 1.90 | -63.26 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 189,842 | 1,798,674 | 10.55 | |
| 277,992 | 1,585,391 | 17.53 | |
| 272,165 | 923,808 | 29.46 | |
| 99,329 | 544,709 | 18.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NAMS – NewAmsterdam Pharma Company N.V. | NGNE – Neurogene Inc. |
| NKGN – NKGen Biotech, Inc. | NTLA – Intellia Therapeutics, Inc. |
| OCS – Oculis Holding AG |
Financial data and stock pages provided by
Fintel.io